Show simple item record

Authordc.contributor.authorCastillo, César del 
Authordc.contributor.authorCabrera C., M. Elena 
Authordc.contributor.authorDerio P., Lea 
Authordc.contributor.authorGaete V., Fancy 
Authordc.contributor.authorCavada Chacón, Gabriel 
Admission datedc.date.accessioned2019-03-18T12:02:06Z
Available datedc.date.available2019-03-18T12:02:06Z
Publication datedc.date.issued2017
Cita de ítemdc.identifier.citationRev Med Chile 2017; 145: 1507-1513
Identifierdc.identifier.issn07176163
Identifierdc.identifier.issn00349887
Identifierdc.identifier.other10.4067/s0034-98872017001201507
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/167426
Abstractdc.description.abstractBackground: Breast cancer is the most common malignant tumor in women in the world. In 2005, it was incorporated to the Explicit Guaranties Health System (GES) in Chile. Aim: To describe the demographic and clinical characteristics of breast cancer patients and to determine the effect of incorporating these women to GES. Material and Methods: Medical records of 5,119 women with breast cancer aged 59 ± 14 years, attended at six public hospitals between 2000 and 2010 were reviewed. Median follow up was 87 months (range 1-182). Mortality was assessed using death certificates obtained at the National Identification Registry. Results: Sixty six percent of women were in stage I-II, 29% in stage III and 5% in stage IV. Surgery was performed in 4023/5119 cases (79%), adyuvant radiotherapy in 3627/4517 cases (80%), chemotherapy in 3,204/3,424 cases (94%) and hormone therapy in 1,695/2,375 cases (71%). Between 2000 and 2010, there was a significant increase in the proportion of cases in stage I, from 8% to 25%, (p < 0.01). Overall survival (OS) increased 1% per year, since the beginning of GES system (p = 0.024). Five year OS was 75.1%. The figures for Stage I, II, III and IV were 93, 84, 62 and 27% respectively (p < 0.01). Patients without lymph node involvement and who were not triple negative, had a significantly better OS. Conclusions: There was a significant increase in stage I cases, and a 1% per year OS improvement after GES system started, compared with the previous period.
Lenguagedc.language.isosp
Publisherdc.publisherSociedad Médica de Santiago
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
Sourcedc.sourceRevista Médica de Chile
Keywordsdc.subjectBreast neoplasm
Keywordsdc.subjectChile
Keywordsdc.subjectTherapeutics
Keywordsdc.subjectTriple negative breast neoplasm
Títulodc.titleResultados del tratamiento del cáncer de mama, Programa Nacional de Cáncer del Adulto
Title in another languagedc.title.alternativeImpact of the Chilean Explicit Guaranties Health System (GES) on breast cancer treatment
Document typedc.typeArtículo de revista
Catalogueruchile.catalogadorlaj
Indexationuchile.indexArtículo de publicación SCOPUS
uchile.cosechauchile.cosechaSI


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile